> Detailanzeige

Goepfert, Christine; Gazdhar, Amiq; Frey, Felix J.; Frey, Brigitte M.

Effect of electroporation‐mediated diphtheria toxin A expression on PSA positive human prostate xenograft tumors in SCID mice

Literatur-
verwaltung

Zur
Merkliste

Lösche von
Merkliste

Per Whatsapp teilen

Schließen

Merkliste



Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
  • Medientyp: E-Artikel
  • Titel: Effect of electroporation‐mediated diphtheria toxin A expression on PSA positive human prostate xenograft tumors in SCID mice
  • Beteiligte: Goepfert, Christine; Gazdhar, Amiq; Frey, Felix J.; Frey, Brigitte M.
  • Erschienen: Wiley, 2011
  • Erschienen in: The Prostate
  • Sprache: Englisch
  • DOI: 10.1002/pros.21303
  • ISSN: 0270-4137; 1097-0045
  • Schlagwörter: Urology ; Oncology
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:title>Abstract</jats:title><jats:sec><jats:title>BACKGROUND</jats:title><jats:p>Current therapies to treat prostate cancer are often limited. Since it has been shown that very low concentrations of diphtheria toxin A (DT‐A) result in abrogation of protein synthesis and apoptosis of cells, DT‐A might serve as an efficient killer in cancer gene therapy. For this purpose we investigated in a quantitative manner using a stereological approach the apoptotic effect of DT‐A in androgen receptor (AR) and prostate specific antigen (PSA) expressing cells after tumor formation in both flanks of SCID mice.</jats:p></jats:sec><jats:sec><jats:title>METHODS</jats:title><jats:p>First, DT‐A plasmid transfection was evaluated, using the lipid formulation DMRIE‐C in C4‐2 prostate cancer xenografts. After detection of an overall high rate of apoptosis by DMRIE‐C alone, plasmid delivery was performed in a second study by electroporation. Finally this method was used to specifically target the AR and PSA expressing cell line C4‐2 using pDT‐A driven by a prostate specific promoter and enhancer (PSE/PSA). PC‐3 cells, being AR and PSA negative, served as controls.</jats:p></jats:sec><jats:sec><jats:title>RESULTS</jats:title><jats:p>The experiments revealed evidence of a reduced growth rate of AR and PSA expressing C4‐2 cells in vitro and in vivo compared to the AR and PSA negative prostate cancer cell line PC‐3. The electroporation technology favored the response compared to DMRIE‐C.</jats:p></jats:sec><jats:sec><jats:title>CONCLUSION</jats:title><jats:p>These results suggest that the local delivery of DT‐A plasmid by electroporation might present a favorable factor to treat prostate cancer. Prostate 71:872–880, 2011. © 2010 Wiley‐Liss, Inc.</jats:p></jats:sec>